Funding of up to €300,000 is available for projects from 12 up to 36 months under the MRCG-HRB Joint Funding Scheme from Breakthrough Cancer Research.

Breakthrough Cancer Research (Breakthrough) is an Irish Medical Cancer Research Charity focused on funding research leading to new treatments for cancers which do not respond or are poorly served by available treatments.

Breakthrough is committed to funding research to improve cancer care and outcomes and we ensure patient benefit is at the core of our efforts.  It emphasises clinically engaged projects, the role of the immune system and look for new interventions or approaches throughout the patient journey which will positively impact survival of patients with the toughest to cure cancers.

More information here